Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Opin Ophthalmol ; 30(6): 506-512, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31589187

ABSTRACT

PURPOSE OF REVIEW: The United States has experienced a dramatic rise in opioid and injection drug use over the past 2 decades. A public health emergency was declared in 2017 and subsequently, there have been several new reports on the rise of endogenous endophthalmitis specifically associated with injection drug use. The purpose of this review is to provide a current perspective of the ocular harms posed by injection drug use. RECENT FINDINGS: The opioid epidemic has prompted several new studies from New England, one of the US regions most heavily affected, that examine the trends and characteristics of injection drug use-associated endogenous endophthalmitis. Patients may delay seeking care and may be infected with a variety of rare and atypical microbes, and as a result clinical appearance may vary widely. Injection drug use also leads to embolic phenomena such as talc retinopathy and septic emboli from endocarditis. HIV is highly associated with injection drug use and although HAART has drastically reduced the morbidity and mortality of HIV-associated infections, a variety of ocular disease may accompany an immunocompromised patient. SUMMARY: Healthcare providers must remain vigilant in the recognition of injection drug use patients with vision loss and ocular inflammation to ensure prompt medical and/or surgical treatment.


Subject(s)
Endophthalmitis/etiology , Opioid Epidemic , Substance Abuse, Intravenous/etiology , Humans
2.
Ocul Immunol Inflamm ; 27(5): 817-820, 2019.
Article in English | MEDLINE | ID: mdl-29723082

ABSTRACT

Purpose: We aim to investigate bacterial and fungal cultures of hypothermic donor corneal storage media (Optisol-GS) and donor rims. Methods: All corneal transplants performed from January 1, 2015 to June 30, 2016 by a single surgeon at a single facility were retrospectively reviewed. Aerobic, anaerobic, and fungal cultures were routinely obtained from all donor rims and cornea storage media. Culture results and clinical courses were recorded. Results: Eighty-four corneal transplants were performed. Five of 84 grafts (5.95%) had positive bacteria donor rim cultures. Fungal donor rim cultures were positive in 5/84 grafts (5.95%) of which two grew Candida spp. Storage media bacterial cultures were positive in 2/84 (2.4%) cultures. Storage media fungal cultures were positive in 1/84 (1.2%) cultures. No patients developed any evidence of clinical infection. Conclusions: Given the increasing rates of postkeratoplasty fungal infections, the identification of positive fungal cultures from donor rims and storage media warrants further evaluation of adding antifungals to storage media.


Subject(s)
Bacteria/isolation & purification , Cornea/microbiology , Corneal Transplantation , Fungi/isolation & purification , Organ Preservation Solutions , Eye Infections, Bacterial/microbiology , Eye Infections, Fungal/microbiology , Female , Humans , Male , Middle Aged , Retrospective Studies , Tissue Donors
4.
Case Rep Infect Dis ; 2017: 9686353, 2017.
Article in English | MEDLINE | ID: mdl-28480087

ABSTRACT

Endogenous endophthalmitis is a rare but feared infectious ocular complication of injection drug use (IDU). The recent opioid epidemic in the United States threatens to increase the incidence of this disease. We report the first case of endogenous endophthalmitis in the United States caused by the emerging fungal pathogen Rhodotorula in an injection drug user which led to no light perception vision (NLP). Worldwide experience with Rhodotorula endogenous endophthalmitis is limited, but existing cases suggest infection by this particular fungal genus has a grim prognosis.

5.
Sci Transl Med ; 7(286): 286ra68, 2015 May 06.
Article in English | MEDLINE | ID: mdl-25947163

ABSTRACT

Even under the most expert care, a properly constructed intestinal anastomosis can fail to heal, resulting in leakage of its contents, peritonitis, and sepsis. The cause of anastomotic leak remains unknown, and its incidence has not changed in decades. We demonstrate that the commensal bacterium Enterococcus faecalis contributes to the pathogenesis of anastomotic leak through its capacity to degrade collagen and to activate tissue matrix metalloproteinase 9 (MMP9) in host intestinal tissues. We demonstrate in rats that leaking anastomotic tissues were colonized by E. faecalis strains that showed an increased collagen-degrading activity and also an increased ability to activate host MMP9, both of which contributed to anastomotic leakage. We demonstrate that the E. faecalis genes gelE and sprE were required for E. faecalis-mediated MMP9 activation. Either elimination of E. faecalis strains through direct topical antibiotics applied to rat intestinal tissues or pharmacological suppression of intestinal MMP9 activation prevented anastomotic leak in rats. In contrast, the standard recommended intravenous antibiotics used in patients undergoing colorectal surgery did not eliminate E. faecalis at anastomotic tissues nor did they prevent leak in our rat model. Finally, we show in humans undergoing colon surgery and treated with the standard recommended intravenous antibiotics that their anastomotic tissues still contained E. faecalis and other bacterial strains with collagen-degrading/MMP9-activating activity. We suggest that intestinal microbes with the capacity to produce collagenases and to activate host metalloproteinase MMP9 may break down collagen in the intestinal tissue contributing to anastomotic leak.


Subject(s)
Anastomotic Leak/pathology , Collagen/chemistry , Enterococcus faecalis/pathogenicity , Intestinal Mucosa/metabolism , Intestines/microbiology , Matrix Metalloproteinase 9/metabolism , Anastomotic Leak/microbiology , Animals , Anti-Bacterial Agents/pharmacology , Caenorhabditis elegans , Cell Line , Humans , Intestines/pathology , Ischemia/pathology , Macrophages/metabolism , Male , Mice , RNA, Ribosomal, 16S/genetics , Rats , Rats, Wistar , Recombinant Proteins/metabolism , Treatment Outcome
6.
J Bacteriol ; 196(2): 504-13, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24244000

ABSTRACT

We recently demonstrated that Pseudomonas aeruginosa PAO1 undergoes a pronounced phenotypic change when introduced into the intestines of rats during surgical injury. Recovered strains displayed a specific phenotype (termed the P2 phenotype) characterized by altered pyocyanin production, high collagenase activity, high swarming motility, low resistance to chloramphenicol, and increased killing of Caenorhabditis elegans compared to the inoculating strain (termed the P1 phenotype). The aims of this study were to characterize the differences between the P. aeruginosa P1 and P2 phenotypes in quorum sensing and competitiveness. We then determined the presence of the P2 phenotype among PAO1 strains from various laboratories. Results demonstrated that P2 cells display accelerated growth during early exponential phase and early activation of quorum-sensing systems and overcome the growth of P1 cells in a mixed population. Among eight PAO1 strains obtained from different laboratories, four exhibited the P2 phenotype. Of 27 mutants analyzed from the P. aeruginosa MPAO1 transposon library, 25 displayed P2 phenotypes. The P2 phenotype in both cases correlated with a lack of expression of mexE or mexF due to mutations in mexT and mexF genes. In summary, strains possessing the P2 phenotype are distributed among PAO1 strains commonly used across a variety of research laboratories. Genetically, they are characterized by various mutations in mexT or mexF.


Subject(s)
Mutation , Pseudomonas aeruginosa/genetics , Animals , Caenorhabditis elegans/microbiology , Gene Knockout Techniques , Mutagenesis, Insertional , Phenotype , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/physiology , Quorum Sensing , Rats , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...